Literature DB >> 6404993

Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis.

G Döring, H J Obernesser, K Botzenhart, B Flehmig, N Høiby, A Hofmann.   

Abstract

Radioimmunoassays were used to determine titers of antibody to alkaline protease (AP) and elastase (Ela) produced by Pseudomonas aeruginosa in sera and bronchial secretions, in vitro production of AP and Ela by P. aeruginosa isolates, and occurrence of these enzymes in bronchial secretions from patients with cystic fibrosis. Titers of serum antibodies to AP ranging from 1:10 to 1:545 and to Ela ranging from 1:10 to 1:725 were found in 83%-88% of patients with cystic fibrosis and chronic lung infections due to P. aeruginosa. Antibody titers in liquified bronchial secretions were approximately 10% of the serum titers. Thirty-one (93%) of 34 isolates produced both proteases in vitro in comparable amounts (concentration of protease in culture supernatant: AP, 0.01-480 micrograms/ml; Ela, 0.02-490 micrograms/ml). AP and Ela were detected in vivo when antibodies to the enzymes were absent. The results suggest that specific immune responses in patients with cystic fibrosis neutralize proteases of P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6404993     DOI: 10.1093/infdis/147.4.744

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

1.  Bacteria associated with obstructive pulmonary disease elaborate extracellular products that stimulate mucin secretion by explants of guinea pig airways.

Authors:  K B Adler; D D Hendley; G S Davis
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

2.  Disruption of respiratory cilia by proteases including those of Pseudomonas aeruginosa.

Authors:  S T Hingley; A T Hastie; F Kueppers; M L Higgins
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

3.  Pseudomonas infections in cystic fibrosis.

Authors:  R H George
Journal:  Arch Dis Child       Date:  1987-05       Impact factor: 3.791

4.  Genome-Wide Survey of Pseudomonas aeruginosa PA14 Reveals a Role for the Glyoxylate Pathway and Extracellular Proteases in the Utilization of Mucin.

Authors:  Jeffrey M Flynn; Chi Phan; Ryan C Hunter
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

5.  Secretion of proteases by Pseudomonas aeruginosa biofilms exposed to ciprofloxacin.

Authors:  Ewa Ołdak; Elzbieta A Trafny
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

6.  Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis.

Authors:  T R Anderson; T C Montie; M D Murphy; V P McCarthy
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

7.  Recovery of Pseudomonas aeruginosa in respiratory specimens from HIV positive patients being evaluated for Pneumocystis carinii pneumonia.

Authors:  R L Doyle; J J Doherty; L H Zimmerman
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

Review 8.  Cystic fibrosis. Infection and immunity to Pseudomonas.

Authors:  R U Sorensen; R L Waller; J D Klinger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

9.  Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis.

Authors:  G Döring; N Høiby
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

10.  Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis.

Authors:  B E Britigan; M B Hayek; B N Doebbeling; R B Fick
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.